Marcie A. Goldstein
Lawyers
Filters
Yellowstone Acquisition $125 million IPO
Davis Polk advised the sole book runner in connection with the initial public offering of 12,500,000 units of Yellowstone Acquisition Company for aggregate proceeds of $125 million…
Decarbonization Plus Acquisition $200 million IPO
Davis Polk advised the underwriters in connection with the $200 million initial public offering of 20,000,000 units of Decarbonization Plus Acquisition Corporation. Each unit consists…
Aligos Therapeutics $150 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $150 million initial public offering of 10,000,000 shares of common stock of Aligos…
Eargo $165.2 million IPO
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 9,029,629 shares of common stock of Eargo, Inc. at $18.00 per share …
Turmeric Acquisition $97.75 million IPO
Davis Polk advised the joint book-running managers in connection with the $97.75 million initial public offering of 9,775,000 units of Turmeric Acquisition Corp., which includes 1,275…
Aziyo Biologics $50 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $50 million initial public offering of common stock by Aziyo Biologics, Inc. The common stock…
PIMCO Dynamic Income Fund follow-on offering
Davis Polk advised the representative of the several underwriters in connection with an SEC-registered offering of shares of beneficial interest of PIMCO Dynamic Income Fund for total…
Vy Global Growth $575 million IPO
Davis Polk advised the underwriters in connection with the $575 million initial public offering of 57,500,000 units of Vy Global Growth, which includes 7,500,000 units from the full…
AEA-Bridges Impact $400 million IPO
Davis Polk advised the representatives of the underwriters in connection with the initial public offering of 40,000,000 units of AEA-Bridges Impact Corp. for aggregate proceeds of $400…
Beam Therapeutics $127 million offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering of 5,750,000 common shares of Beam Therapeutics Inc. for total gross proceeds of $127…